Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087079268> ?p ?o ?g. }
- W3087079268 endingPage "2216" @default.
- W3087079268 startingPage "2211" @default.
- W3087079268 abstract "ABSTRACT Chimeric antigen receptor (CAR) T cell therapy is approved in the United States for the treatment of acute lymphocytic leukemia and aggressive B cell lymphomas. Multiple cardiovascular adverse events (CVEs) associated with CAR-Ts have been observed in small studies, but no large-scale studies exist. Leveraging the Food and Drug Administration (FDA) Adverse Events Reporting System (FAERS), we identified all reported adverse events (AEs) associated with CAR-T therapy (tisagenlecleucel and axicabtagene ciloleucel) from 2017 to 2019. Reports with missing age and sex were excluded. CVEs were classified into arrhythmias, heart failure (HF), myocardial infarction (MI), and other CVEs. Logistic regression and hierarchical clustering were used to identify factors associated with CVEs. A total of 996 reported AEs were observed (39.1% associated with tisagenlecleucel and 60% with axicabtagene ciloleucel). Of all patients experiencing AEs, the median age was 54 (interquartile range, 21 to 65) years; 38.9% were females. In total, 19.7% (196) of all AEs reported to the FDA were CVEs. The most common CVEs were arrhythmia (77.6%), followed by HF (14.3%) and MI (0.5%). In adjusted analysis a positive association was observed between those presenting with CVE with neurotoxicity (odds ratio, 1.76; 95% confidence interval, 1.20 to 2.60; P = .004). Additionally, when both CVE and cytokine release syndrome (CRS) are present, neurotoxicity is the most common noncardiac AE, which clusters with them (Jaccard similarity: 73.1). The mortality rate was 21.1% overall but 30.1% for those reporting CVEs. In FAERS, reported CVEs with CAR-T are associated with high reported mortality. The development of either CRS or neurotoxicity should prompt vigilance for cardiovascular events." @default.
- W3087079268 created "2020-09-25" @default.
- W3087079268 creator A5011534811 @default.
- W3087079268 creator A5019014469 @default.
- W3087079268 creator A5033046325 @default.
- W3087079268 creator A5034264716 @default.
- W3087079268 creator A5041444092 @default.
- W3087079268 creator A5044991433 @default.
- W3087079268 creator A5052007080 @default.
- W3087079268 creator A5060038195 @default.
- W3087079268 creator A5065015589 @default.
- W3087079268 date "2020-12-01" @default.
- W3087079268 modified "2023-10-16" @default.
- W3087079268 title "Cardiovascular Events Associated with Chimeric Antigen Receptor T Cell Therapy: Cross-Sectional FDA Adverse Events Reporting System Analysis" @default.
- W3087079268 cites W1495300968 @default.
- W3087079268 cites W1998025025 @default.
- W3087079268 cites W1998871699 @default.
- W3087079268 cites W2003304924 @default.
- W3087079268 cites W2027804043 @default.
- W3087079268 cites W2056780622 @default.
- W3087079268 cites W2082708772 @default.
- W3087079268 cites W2085080020 @default.
- W3087079268 cites W2099570622 @default.
- W3087079268 cites W2608364534 @default.
- W3087079268 cites W2754562068 @default.
- W3087079268 cites W2763751953 @default.
- W3087079268 cites W2773804840 @default.
- W3087079268 cites W2787301955 @default.
- W3087079268 cites W2787621143 @default.
- W3087079268 cites W2887277557 @default.
- W3087079268 cites W2903062212 @default.
- W3087079268 cites W2905654445 @default.
- W3087079268 cites W2916176185 @default.
- W3087079268 cites W2919640907 @default.
- W3087079268 cites W2922411150 @default.
- W3087079268 cites W2944998775 @default.
- W3087079268 cites W2968843497 @default.
- W3087079268 cites W2969320113 @default.
- W3087079268 cites W2976280418 @default.
- W3087079268 cites W2995318619 @default.
- W3087079268 cites W2995487842 @default.
- W3087079268 cites W2996304730 @default.
- W3087079268 cites W3011906108 @default.
- W3087079268 cites W3012061428 @default.
- W3087079268 doi "https://doi.org/10.1016/j.bbmt.2020.08.036" @default.
- W3087079268 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32966880" @default.
- W3087079268 hasPublicationYear "2020" @default.
- W3087079268 type Work @default.
- W3087079268 sameAs 3087079268 @default.
- W3087079268 citedByCount "36" @default.
- W3087079268 countsByYear W30870792682021 @default.
- W3087079268 countsByYear W30870792682022 @default.
- W3087079268 countsByYear W30870792682023 @default.
- W3087079268 crossrefType "journal-article" @default.
- W3087079268 hasAuthorship W3087079268A5011534811 @default.
- W3087079268 hasAuthorship W3087079268A5019014469 @default.
- W3087079268 hasAuthorship W3087079268A5033046325 @default.
- W3087079268 hasAuthorship W3087079268A5034264716 @default.
- W3087079268 hasAuthorship W3087079268A5041444092 @default.
- W3087079268 hasAuthorship W3087079268A5044991433 @default.
- W3087079268 hasAuthorship W3087079268A5052007080 @default.
- W3087079268 hasAuthorship W3087079268A5060038195 @default.
- W3087079268 hasAuthorship W3087079268A5065015589 @default.
- W3087079268 hasBestOaLocation W30870792681 @default.
- W3087079268 hasConcept C142052008 @default.
- W3087079268 hasConcept C142724271 @default.
- W3087079268 hasConcept C143998085 @default.
- W3087079268 hasConcept C197934379 @default.
- W3087079268 hasConcept C203014093 @default.
- W3087079268 hasConcept C2777105317 @default.
- W3087079268 hasConcept C2777701055 @default.
- W3087079268 hasConcept C3875195 @default.
- W3087079268 hasConcept C71924100 @default.
- W3087079268 hasConcept C8891405 @default.
- W3087079268 hasConcept C98274493 @default.
- W3087079268 hasConceptScore W3087079268C142052008 @default.
- W3087079268 hasConceptScore W3087079268C142724271 @default.
- W3087079268 hasConceptScore W3087079268C143998085 @default.
- W3087079268 hasConceptScore W3087079268C197934379 @default.
- W3087079268 hasConceptScore W3087079268C203014093 @default.
- W3087079268 hasConceptScore W3087079268C2777105317 @default.
- W3087079268 hasConceptScore W3087079268C2777701055 @default.
- W3087079268 hasConceptScore W3087079268C3875195 @default.
- W3087079268 hasConceptScore W3087079268C71924100 @default.
- W3087079268 hasConceptScore W3087079268C8891405 @default.
- W3087079268 hasConceptScore W3087079268C98274493 @default.
- W3087079268 hasFunder F4320310847 @default.
- W3087079268 hasIssue "12" @default.
- W3087079268 hasLocation W30870792681 @default.
- W3087079268 hasOpenAccess W3087079268 @default.
- W3087079268 hasPrimaryLocation W30870792681 @default.
- W3087079268 hasRelatedWork W1669499790 @default.
- W3087079268 hasRelatedWork W1967736925 @default.
- W3087079268 hasRelatedWork W2153634070 @default.
- W3087079268 hasRelatedWork W2561881413 @default.
- W3087079268 hasRelatedWork W2984657441 @default.
- W3087079268 hasRelatedWork W3011938841 @default.
- W3087079268 hasRelatedWork W3080774186 @default.